FDA Approves LEQEMBI (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
TOKYO and CAMBRIDGE, Mass., Jan 28, 2src25 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that...
TOKYO and CAMBRIDGE, Mass., Jan 28, 2src25 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that...